| scholarly article | Q13442814 |
| P2093 | author name string | K Blum | |
| R D Badgaiyan | |||
| P K Thanos | |||
| D Baron | |||
| T McLaughlin | |||
| M Moran | |||
| I Elman | |||
| W Jacobs | |||
| D Siwicki | |||
| E J Modestino | |||
| E R Braverman | |||
| N DiNubile | |||
| P2860 | cites work | Epigenetic mechanisms of drug addiction | Q22251252 |
| Melanocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humans | Q24673415 | ||
| Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review | Q27026097 | ||
| Does it take too long to publish research? | Q28273194 | ||
| Impact of a Mandatory Prescription Drug Monitoring Program on Prescription of Opioid Analgesics by Dentists | Q28547271 | ||
| Fifty Years in the Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome: A Pictorial | Q28821669 | ||
| A 1980 Letter on the Risk of Opioid Addiction | Q30241315 | ||
| Interoception beyond homeostasis: affect, cognition and mental health | Q30369549 | ||
| Long term Suboxone™ emotional reactivity as measured by automatic detection in speech | Q30452109 | ||
| Resting state functional connectivity: its physiological basis and application in neuropharmacology | Q30665449 | ||
| The effectiveness of the peer review process: inter-referee agreement and predictive validity of manuscript refereeing at Angewandte Chemie | Q33355090 | ||
| Repetitive H-wave device stimulation and program induces significant increases in the range of motion of post operative rotator cuff reconstruction in a double-blinded randomized placebo controlled human study | Q33513735 | ||
| Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z. | Q33605694 | ||
| Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(R) device therapy: a case series | Q33702298 | ||
| Implications of genome wide association studies for addiction: are our a priori assumptions all wrong? | Q34358797 | ||
| Remembering the forgotten non-communicable diseases | Q34394682 | ||
| Allelic association of human dopamine D2 receptor gene in alcoholism | Q34998499 | ||
| Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction | Q36741881 | ||
| Fate of manuscripts declined by the Journal of the American Academy of Dermatology. | Q37077019 | ||
| rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts | Q37164595 | ||
| Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic review | Q37200568 | ||
| The H-Wave device is an effective and safe non-pharmacological analgesic for chronic pain: a meta-analysis | Q37219554 | ||
| Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms | Q37237466 | ||
| Addiction treatment centers' progress in preparing for health care reform | Q37419471 | ||
| Peer review practices in biomedical literature: a time for change? | Q37628268 | ||
| Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians. | Q37679687 | ||
| To accept or reject? A guide to peer reviewing of medical journal papers. | Q38033952 | ||
| Surgical options for complex craniofacial pain | Q38252837 | ||
| Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land? | Q38479762 | ||
| Resting state functional connectivity analysis for addiction medicine: From individual loci to complex networks | Q38715360 | ||
| Modulation of pain, nociception, and analgesia by the brain reward center | Q38836955 | ||
| The H-Wave((R)) Device Induces NODependent Augmented Microcirculation and Angiogenesis, Providing Both Analgesia and Tissue Healing in Sports Injuries | Q39293384 | ||
| H-Wave, a nonpharmacologic alternative for the treatment of patients with chronic soft tissue inflammation and neuropathic pain: a preliminary statistical outcome study | Q39347313 | ||
| History of The Joint Commission's Pain Standards: Lessons for Today's Prescription Opioid Epidemic | Q40316715 | ||
| Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence | Q41996105 | ||
| Vermont responds to its opioid crisis | Q42174073 | ||
| Overcoming qEEG Abnormalities and Reward Gene Deficits during Protracted Abstinence in Male Psychostimulant and Polydrug Abusers Utilizing Putative Dopamine D2Agonist Therapy: Part 2 | Q42805286 | ||
| Assessing peer review by gauging the fate of rejected manuscripts: the case of the Journal of Artificial Societies and Social Simulation | Q43521922 | ||
| Genetic variation in morphine analgesic tolerance: a survey of 11 inbred mouse strains | Q44126663 | ||
| White House expands opioid addiction response: Treat chronic pain like other chronic conditions, pharmacists say. | Q44334224 | ||
| Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ. | Q44343660 | ||
| Diabetic peripheral neuropathy: amelioration of pain with transcutaneous electrostimulation | Q45174853 | ||
| Positive association between--1021TT genotype of dopamine beta hydroxylase gene and progressive behavior of injection heroin users | Q45248842 | ||
| LG839: anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome | Q46378917 | ||
| Addiction medicine and the free clinic movement | Q46422605 | ||
| A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxone | Q47282815 | ||
| Addiction Treatment in America: After Money or Aftercare? | Q47575315 | ||
| Methionine enkephalin as a possible neuromodulator of regional cerebral blood flow | Q48469980 | ||
| The H-Wave small muscle fiber stimulator, a nonpharmacologic alternative for the treatment of chronic soft-tissue injury and neuropathic pain: an extended population observational study. | Q51098487 | ||
| Decreasing pain in electrical nerve stimulation. | Q51253346 | ||
| Innate properties of H-Wave device, a small fiber stimulator provides the basis for a paradigm shift of electro-therapeutic treatment of pain with increased functional restoration associated with human neuropathies by affecting tissue circulation: a | Q51525952 | ||
| Distinct resting-state brain activities in heroin-dependent individuals. | Q52298883 | ||
| How Good Intentions Contributed to Bad Outcomes: The Opioid Crisis. | Q52316069 | ||
| The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. | Q55331780 | ||
| THE BENEFITS OF CUSTOMIZED DNA DIRECTED NUTRITION TO BALANCE THE BRAIN REWARD CIRCUITRY AND REDUCE ADDICTIVE BEHAVIORS | Q56892520 | ||
| H-Wave induces arteriolar vasodilation in rat striated muscle via nitric oxide-mediated mechanisms | Q83320767 | ||
| Guideline for Prescribing Opioids for Chronic Pain | Q87666480 | ||
| GLOBAL OPIOID EPIDEMIC: DOOMED TO FAIL WITHOUT GENETICALLY BASED PRECISION ADDICTION MEDICINE (PAM™): LESSONS LEARNED FROM AMERICA | Q94417368 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | peer review | Q215028 |
| P304 | page(s) | 1-11 | |
| P577 | publication date | 2018-10-04 | |
| P1476 | title | Insurance Companies Fighting the Peer Review Empire without any Validity: the Case for Addiction and Pain Modalities in the face of an American Drug Epidemic | |
| P478 | volume | 1 |
| Q89822037 | Americas' opioid/psychostimulant epidemic would benefit from general population early identification of genetic addiction risk especially in children of alcoholics (COAs) | cites work | P2860 |
Search more.